This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Zacks.com featured highlights include: Medifast, USANA Health Sciences, UFP Industries, EMCOR and AllianceBernstein
by Zacks Equity Research
Zacks.com featured highlights include: Medifast, USANA Health Sciences, UFP Industries, EMCOR and AllianceBernstein
Can Medifast (MED) Keep the Earnings Surprise Streak Alive?
by Zacks Equity Research
Medifast (MED) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
At-Home Food Consumption is Likely to Keep Growing: 5 Picks
by Ansuiya Mohta
Mounting fears related to coronavirus have raised vulnerability, making at-home food consumption the new normal.
Is MEDIFAST INC (MED) Stock Outpacing Its Consumer Staples Peers This Year?
by Zacks Equity Research
Is (MED) Outperforming Other Consumer Staples Stocks This Year?
Zacks.com featured highlights include: A10 Networks, Fortinet, Valmont Industries and Medifast
by Zacks Equity Research
Zacks.com featured highlights include: A10 Networks, Fortinet, Valmont Industries and Medifast
4 Best-in-Bracket Liquid Stocks for Alluring Returns
by Zacks Equity Research
Here are four top-ranked liquid gems, including Fortinet (FTNT), that investors can add to portfolio for remarkable returns.
Lamb Weston's Solid Price/Mix Bodes Well, High Costs Hurt
by Zacks Equity Research
Lamb Weston (LW) looks well poised on robust price/mix, focus on LTOs and capacity expansion. However, higher input and manufacturing costs are concerning.
The Zacks Analyst Blog Highlights: BlackRock, Taiwan Semiconductor Manufacturing Company, MEDIFAST, Air Products and Chemicals and Juniper Networks
by Zacks Equity Research
The Zacks Analyst Blog Highlights: BlackRock, Taiwan Semiconductor Manufacturing Company, MEDIFAST, Air Products and Chemicals and Juniper Networks
Is 60/40 Rule Obsolete Now? 5 Dividend Stocks to Buy
by Sanghamitra Saha
Strategists from Bank of America and J.P. Morgan now see the end of success in the 60-40 standard portfolio.
6 Solid Stocks to Tide Over the Second Coronavirus Wave
by Ritujay Ghosh
Life has changed in the past few months with people adapting themselves to work and learn from remote locations.
5 DuPont-Tested Winning Stocks
by Sanghamitra Saha
Use the DuPont technique to pick solid profit-generating stocks.
3 Reasons Why Flowers Foods Appears to be a Lucrative Pick
by Zacks Equity Research
Flowers Foods (FLO) has been benefiting from increased at-home consumption amid the pandemic. Also, the company's pricing efforts and saving plans bode well.
Conagra (CAG) Q4 Earnings & Sales Top Estimates, Rise Y/Y
by Zacks Equity Research
Conagra's (CAG) fourth-quarter fiscal 2020 results reflect gains from increased at-home consumption amid the pandemic. This boosted the company's retail business.
Packaged Food Demand Grows as Coronavirus Fears Spike: 4 Winners
by Ritujay Ghosh
An increasing number of people are opting for comfort food at home given that most restaurants and cafes remain closed.
Moving Average Crossover Alert: Medifast
by Zacks Equity Research
Medifast, Inc. (MED) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.
The Zacks Analyst Blog Highlights: Medifast, Ollie's, Beyond Meat, Hain Celestial and Clorox
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Medifast, Ollie's, Beyond Meat, Hain Celestial and Clorox
Is MEDIFAST INC (MED) Outperforming Other Consumer Staples Stocks This Year?
by Zacks Equity Research
Is (MED) Outperforming Other Consumer Staples Stocks This Year?
Buy 5 Top Consumer Staple Stocks to Minimize Portfolio Risks
by Nalak Das
It will be prudent to invest in consumer staple stocks with a favorable Zacks Rank to minimize portfolio risks.
DuPont: A Less-Traversed Path to Pick 5 Winning Stocks
by Sanghamitra Saha
Have more faith in DuPont analysis than simple ROE calculation? Bet on these five stocks.
The Zacks Analyst Blog Highlights: The Clorox Company, Medifast, Flowers Foods, Kimberly-Clark and Nu Skin Enterprises
by Zacks Equity Research
The Zacks Analyst Blog Highlights: The Clorox Company, Medifast, Flowers Foods, Kimberly-Clark and Nu Skin Enterprises
5 Consumer Staple Dividend Stocks to Enrich Your Portfolio
by Vrishali Bagree
At a juncture where many companies have suspended dividends due to the coronavirus crisis, we have picked five consumer staple stocks, which are continuing with dividend payments.
Medifast (MED) is an Incredible Growth Stock: 3 Reasons Why
by Zacks Equity Research
Medifast (MED) possesses solid growth attributes, which could help it handily outperform the market.
6 Top-Ranked Liquid Stocks to Bet on for a Winning Portfolio
by Zacks Equity Research
Here are six top-ranked liquid gems, including Fortinet (FTNT), that investors can add to their portfolio for remarkable returns.
Mismatch in Main Street & Wall Street? 4 Quality Picks
by Sanghamitra Saha
With rising uncertainty and a global recessionary environment, investors may consider parking money in quality stocks.
Sysco (SYY) Looks Well Poised on Diversified Business Lines
by Zacks Equity Research
Sysco (SYY) is likely to gain from its efforts to boost revenues by tapping diversified business channels.